Human Vaccines & Immunotherapeutics (Dec 2024)
Response to comment on: “Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis”
Abstract
No abstracts available.
Human Vaccines & Immunotherapeutics (Dec 2024)